NLRP3 inflammasome activation drives tau pathology

[1]  I. Dewachter,et al.  Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo , 2019, Acta Neuropathologica.

[2]  M. Heneka,et al.  Inflammasome signalling in brain function and neurodegenerative disease , 2018, Nature Reviews Neuroscience.

[3]  S. Finkbeiner,et al.  The Arc of cognition: Signaling cascades regulating Arc and implications for cognitive function and disease. , 2018, Seminars in cell & developmental biology.

[4]  A. Katsarou,et al.  Reporting for specific materials, systems and methods , 2018 .

[5]  M. Heneka,et al.  Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration , 2018, Cell Death & Disease.

[6]  M. Heneka,et al.  Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease , 2017, Nature.

[7]  D. Holtzman,et al.  AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy , 2017, The Journal of experimental medicine.

[8]  D. Castillo-Carranza,et al.  Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage , 2017, Front. Aging Neurosci..

[9]  L. Buée,et al.  Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy , 2016, Brain : a journal of neurology.

[10]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[11]  Jennifer Luebke,et al.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.

[12]  J. Renger,et al.  Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells , 2015, The Journal of Neuroscience.

[13]  Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitro , 2015, Journal of Neuroinflammation.

[14]  Dennis W. Dickson,et al.  Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.

[15]  P. Adlard,et al.  Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease , 2014, Neurobiology of Aging.

[16]  D. Holtzman,et al.  Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.

[17]  D. Ingram,et al.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. , 2013, Cell metabolism.

[18]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[19]  A. Goate,et al.  Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies* , 2012, The Journal of Biological Chemistry.

[20]  N. Lago,et al.  Overexpression of the Immunoreceptor CD300f Has a Neuroprotective Role in a Model of Acute Brain Injury , 2012, Brain pathology.

[21]  R. Kayed,et al.  Preparation and characterization of neurotoxic tau oligomers. , 2010, Biochemistry.

[22]  R. Ransohoff,et al.  Regulation of Tau Pathology by the Microglial Fractalkine Receptor , 2010, Neuron.

[23]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[24]  S. Ficarro,et al.  Targeted Disruption of the PME-1 Gene Causes Loss of Demethylated PP2A and Perinatal Lethality in Mice , 2008, PloS one.

[25]  M. Staufenbiel,et al.  Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice , 2007 .

[26]  M. Staufenbiel,et al.  Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. , 2007, The American journal of pathology.

[27]  L. Buée,et al.  P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.

[28]  S. Akira,et al.  Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 , 2006, Nature.

[29]  I. Grundke‐Iqbal,et al.  Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.

[30]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.